Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings

January 21, 2026 UCBN News, Syndication Comments Off on Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings

REDWOOD CITY, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it will present a poster at the upcoming 2026 Tandem Meetings | Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

News

dōTERRA Becomes a Member of UEBT – Reinforcing its Commitment to Sourcing with Respect for People and Biodiversity

October 21, 2025 UCBN News, Syndication Comments Off on dōTERRA Becomes a Member of UEBT – Reinforcing its Commitment to Sourcing with Respect for People and Biodiversity

PLEASANT GROVE, Utah, Oct. 21, 2025 /PRNewswire/ — dōTERRA, the global leader in essential oils and natural wellness products, is proud to announce its membership status with the Union for Ethical BioTrade (UEBT). As a […]

No Picture
News

New Scientific Study Confirms 80% Methane Emission Reduction From Dairy Manure Using SOP® Lagoon

June 20, 2023 UCBN News, Syndication Comments Off on New Scientific Study Confirms 80% Methane Emission Reduction From Dairy Manure Using SOP® Lagoon

PARK CITY, Utah–(BUSINESS WIRE)–Resonant Technology Group (“Resonant”) is excited to announce profound scientific results from their product, SOP® Lagoon, which provides unrivaled GHG emission reductions and sustainability benefits to the beef and dairy industries. Joint […]